OUR STORY / AVA HAUCK

It started with a science fair.

The story of how curiosity, self-directed learning, and a small-town perspective became Clinivue.

SCROLL TO EXPLORE
Portrait of Ava Hauck, founder and CEO of Clinivue

FOUNDER & CEO

Ava Hauck

Ava began independent science research in eighth grade. By 15, the question had shifted toward medical diagnostics. At 16, the research began becoming a company.

“I didn’t need to know whether I could pull it off. I needed to know whether I cared enough to try.”
8th grade

CHAPTER 01

The science fair

A light-pollution project introduced Ava to independent research. Curiosity came before the company.

Clinivue founder-story milestone
Age 15

CHAPTER 02

The question changes

A family experience with leukemia shifted her attention toward diagnostic medicine and the gaps surrounding access.

Clinivue founder-story milestone
Age 16

CHAPTER 03

Research becomes Clinivue

Self-directed work in coding, computer vision, microscopy, optics, and engineering began taking the shape of a company.

Clinivue founder-story milestone
2026

CHAPTER 04

Build. Test. Repeat.

Prototype systems, software experiments, research presentations, patent work, and laboratory validation continued in parallel.

Clinivue founder-story milestone

BUILDING Clinivue

From code and notebook drawings to optics, hardware, research, and validation.

Not a résumé. A documentary record of the work itself.

Late-night Clinivue software development across multiple displays
01 / SOFTWARE

Research became code.

Microscopy images, processing tools, datasets, and software iterations developed side by side.

Clinivue electronics and mechanical components during hands-on prototyping
02 / ENGINEERING

Code needed hardware.

Displays, motors, imaging components, controllers, and computing were assembled into working systems.

Early cardboard Clinivue microscope prototype beside a development laptop
03 / PROTOTYPE

Every version answered a question.

Early physical mockups made the intended workflow tangible before polished enclosures existed.

Microscope, prepared slides, and Clinivue software during research
04 / RESEARCH

Hardware returned to evidence.

Imaging, software, microscopy, and validation remained one connected development loop.

Research became software.

Software became hardware.

Hardware became Clinivue.

ORIGIN / 46.8792° N · 102.7896° W

DICKINSON
  1. NORTH AMERICA
  2. UNITED STATES
  3. NORTH DAKOTA
  4. DICKINSON

Built in Dickinson. Designed for places far beyond it.

Technology does not have to start in a technology hub.

Ava Hauck working in her Clinivue research space in Dickinson, North DakotaThis is where Clinivue was built.

OFFICIAL MAP / DICKINSON, ND

46.8792° N
102.7896° W

Southwestern North Dakota · Stark County · United States

Open Dickinson in Google Maps ↗

PROTOTYPE EVOLUTION

An idea became hardware.

The earliest work happened across kitchen tables, bedroom desks, science-fair boards, and improvised prototype setups.

Early Clinivue paper device concepts and microscope setupClinivue prototype electronics and imaging setupClinivue research presentation and imaging results
AVAMENTORRESEARCHERDOCTORENGINEERLABPARTNER

THE NETWORK

One person taking an idea seriously can change its trajectory.

A chance conversation at a hair salon became one connection, then several more. Clinivue’s network grew because people chose to open doors.

“TOO ADVANCED?”

Build anyway.

Ava’s research workspace in Dickinson, North Dakota
“In North Dakota, it is so quiet that your dreams become so loud you can’t walk away.”

Clinivue was not built despite North Dakota. It was built there—with community support, a rural perspective, and ambition shaped outside a major technology hub.

THE WORK SO FAR

Milestones with a pulse.

$50K+Grant support
$10KCrowdfunding
250+Software-development hours
30+Doctors & professors engaged
4Laboratories engaged
3Provisional patent filings
1Non-provisional application
$120K+Scholarship recognition
Company-reported milestones. Grant support is research and development funding, not venture-capital investment.